Covered recipient · General Payments record
ISSAC M ESSEESSE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,724.41
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $791.41 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genmab U.S., Inc. | $121.92 | 1 |
| SOBI, INC | $121.03 | 1 |
| Janssen Biotech, Inc. | $121.00 | 1 |
| Blueprint Medicines Corporation | $120.83 | 1 |
| Stemline Therapeutics Inc. | $110.01 | 1 |
| AVEO Pharmaceuticals, Inc. | $108.84 | 1 |
| BeiGene USA, Inc. | $87.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aveo Pharmaceuticals, Inc. | $108.84 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143478857 | CMS |
| BeiGene USA, Inc. | $87.78 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120860475 | CMS |
| Blueprint Medicines Corporation | $120.83 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147449514 | CMS |
| Genmab U.S., Inc. | $121.92 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126827320 | CMS |
| Janssen Biotech, Inc. | $121.00 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078481570 | CMS |
| SOBI, INC | $121.03 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141422823 | CMS |
| Stemline Therapeutics Inc. | $110.01 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142960479 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.